LMRI

Business Context and Reporting Period

Lumexa Imaging Holdings, Inc. (LMRI) is a national provider of diagnostic imaging services operating 192 outpatient imaging centers across 14 states as of June 30, 2026. The company operates through two segments: Outpatient Imaging Centers and Professional Services. It utilizes a hybrid ownership model, consolidating 104 centers while accounting for 88 joint venture centers under the equity method. This filing covers the quarterly and six-month periods ended June 30, 2026.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 5.1% year-over-year for the quarter and 4.1% for the six-month period. This was driven by a 2.9% increase in net patient service revenue and an 80.6% increase in management fee revenue (quarterly), largely due to new contracts and pass-through costs.
• Profitability: The company returned to profitability, reporting net income of $2.7 million for the quarter compared to a net loss of $7.2 million in the prior year quarter. For the six months ended June 30, 2026, net income was $4.5 million versus a loss of $14.9 million in the prior year.
• Interest Expense Reduction: Interest expense decreased significantly by 46.1% for the quarter and 45.7% for the six-month period. This reduction resulted from a debt refinancing in December 2025 and a subsequent amendment in June 2026 that lowered the interest rate from SOFR + 3.0% to SOFR + 2.5%.
• Operating Expenses: Cost of operations increased 6.1% (quarterly) and 5.3% (six-month) due to higher volumes, salaries, and physician compensation. General and administrative expenses rose 30.5% (quarterly) primarily due to increased stock-based compensation following the IPO.

Outlook, Risks, and Unusual Items

• Debt Refinancing: In June 2026, the company executed Amendment No. 7 to its credit agreement, reducing interest rates. This incurred a $1.1 million loss on extinguishment and modification of debt.
• Internal Control Weaknesses: Management concluded that disclosure controls and procedures were not effective as of June 30, 2026, due to material weaknesses in the control environment, risk assessment, revenue accounting, segregation of duties, and IT general controls. These weaknesses were not remediated as of the filing date.
• Cybersecurity Incident: In April 2026, a vendor data breach involving protected health information was disclosed. While no material interruption to operations occurred, putative class action lawsuits were filed in May 2026. Management does not currently believe this will have a material adverse effect.
• Guidance: The filing does not provide specific forward-looking financial guidance for the full year 2026, though management expects operating expenses to increase in the near term due to public company compliance costs.

Investor Verification Checklist

• Remediation of Material Weaknesses: Verify the progress of the remediation plan for the five identified material weaknesses in internal controls over financial reporting.
• Debt Covenants: Confirm continued compliance with the Amended Credit Agreement covenants, specifically the net leverage ratio trigger if revolving credit exposure exceeds 40%.
• Unconsolidated Affiliate Performance: Review the financial health of the 88 unconsolidated joint venture centers, which contribute significantly to equity in earnings and management fees.
• Cybersecurity Liability: Monitor the status of the class action lawsuits and potential remediation costs arising from the April 2026 vendor data breach.
• Stock-Based Compensation: Assess the sustainability of the increased stock-based compensation expense following the IPO and its impact on future GAAP net income.